Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStreaksai Regulatory News (STK)

  • There is currently no data for STK

Board Appointments

20 Feb 2023 07:00

RNS Number : 3650Q
Streaks Gaming PLC
20 February 2023
 

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain. 

20 February 2023

Streaks Gaming PLC

("Streaks" or "the Company")

Board Appointments

London, United Kingdom - Streaks Gaming PLC (LSE: STK), a GPT-driven conversational gaming platform targeting customers in the emerging US sports betting market is pleased to announce the following appointments to its Board of Directors.

Philip Blows has been appointed as Executive Director and Digby Try has been appointed as Non Executive Director. Both appointments will take effect on 20 February 2023.

Philip Blows brings more than 17 years of leadership experience in the platform, fintech, and asset management sectors where he co-founded and spearheaded the scaling-up of listed crypto exchange and startup incubator AQRU Plc. His previous experience includes as Director at Wealth Wizards, a UK robo-advice platform; senior foreign exchange adviser at Continental Capital Markets S.A and head of trading at Moneycorp. Philip graduated from the University of Leeds and went on to gain an MBA from the University of Geneva. He holds several internationally recognised financial certifications and qualifications, including an Investment Management Certificate from the CFA Institute and has been certified a Blockchain Expert by the Blockchain Council. He is also the author of a personal finance book, The Money Triangle.

Digby Try has a track record of over 20 years in senior management roles in the currency, payments and fintech sectors in both the UK and US. Digby is co-founder of AQRU Plc where he manages the growth of the cryptocurrency platform and subsidiary businesses. Previously, he was Head of Global Sales at OpenPayd, a technology-led banking and payments platform for businesses, where he specialised in delivering fiat banking rails to the crypto industry and worked alongside many of the world's leading exchanges. His previous experience includes seven years as Vice President of Sales EMEA at Currencycloud, which was subsequently acquired by Visa for £700m; three years as business development manager at Moneycorp and five years at HiFX (now XE.com), including as head of dealing in the US. Digby is a graduate of the University of East Anglia.

Philip Blows and Digby Try are both Directors of AQRU Plc which has a 20.2% interest in the equity of Streaks.

Mark Rutledge, Chief Executive Officer of Streaks, commented: "I am delighted to welcome Phil and Digby to the board of Streaks. Their respective track record developing products and scaling businesses in the fintech space will be invaluable in our goal to make Streaks a global leader in the AI driven conversation gaming space".

Were LR 9.6.13 to apply to the Company, there would be no further information to disclose.

For more information, please visit Streaks Gaming PLC's website at playstreaks.com.

 

Contact

 

Streaks Gaming Plc

 

Mike Edwards

Non-Executive Chairman

Via First Sentinel

+44 203 989 2222

Tennyson Securities

 

Corporate Broker

Peter Krens

 

+44 207 186 9030

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADBGDDBUBDGXC
12
Date   Source Headline
13th May 20253:26 pmRNSChange of Company Name and Strategic Update
29th Jan 20257:00 amRNSExercise of Warrants, PDMR and Grant of Warrants
24th Jan 202510:01 amRNSOperations Update
16th Jan 20259:23 amRNSLeadership Changes and Board Appointments
15th Jan 202512:20 pmRNSNotification of Investment
26th Nov 20249:43 amRNSTR-1 Notification
22nd Nov 20247:00 amRNSIssue of Warrants and PDMR
21st Nov 20247:00 amRNSIssue of Equity and PDMR
18th Nov 20247:00 amRNSInterim results
2nd Aug 202411:16 amRNSDirector Resignation
25th Jul 20245:57 pmRNSResults of Annual General Meeting
4th Jul 20244:28 pmRNSNotice of Annual General Meeting
28th Jun 20247:00 amRNSAnnual results
11th Mar 202410:31 amRNSDirector's Dealings
4th Mar 20245:09 pmRNSDirector Resignation
2nd Feb 202410:02 amRNSDirector Resignation
19th Dec 20231:10 pmRNSDirector's Dealings and TR-1 Notification
30th Nov 20237:00 amRNSInterim Results
2nd Nov 20237:00 amRNSLaunch of Streaks Companion
21st Sep 20237:00 amRNSLaunch of Streaks Idols Social Product
29th Aug 20237:00 amRNSChange of Board Composition
16th Aug 202312:45 pmRNSResults of Annual General Meeting
3rd Aug 20237:00 amRNSPartnership with WeShop
17th Jul 20237:00 amRNSNotice of AGM
10th Jul 20237:00 amRNSChange of Name
30th Jun 20237:03 amRNSAnnual Results
30th Jun 20237:00 amRNSStreaks Social AI Product Launch / Warrants Issue
24th Mar 20237:00 amRNSAdvertising Partnership with William Hill US
20th Feb 20237:00 amRNSBoard Appointments
2nd Feb 20237:00 amRNSFanDuel Partnership
18th Jan 20237:00 amRNSYear-over-Year Performance
5th Jan 20237:00 amRNSAdmission to the Official List
8th Aug 200810:08 amRNSStatement re Forecast of Year
10th Jun 200812:16 pmRNSStatement re Dividends Receip
6th Jun 200811:06 amRNSStatement re Partial Correcti
30th May 200810:17 amRNSStatement re Concerning Disso
23rd May 200812:47 pmRNSStatement re Announcement of
23rd May 200810:50 amRNSRe Partial Changes in Article
23rd May 200810:32 amRNSStatement re Concerning Parti
23rd May 200810:29 amRNSStatement re Correction of Fi
23rd May 200810:15 amRNSStatement re Conceming Correc
25th Apr 200812:46 pmRNSAcquisition of Shares
25th Apr 200812:42 pmRNSValuation.@Loss
27th Mar 20089:28 amRNSStatement re Transfer
31st Jan 200812:01 pmRNSStatement re Special Loss
28th Nov 200710:31 amRNSStatement re Earnings
29th Jun 200710:08 amRNSStatement re Securitization
22nd Jun 200711:43 amRNSStatement re (Dividend)
21st Jun 20071:14 pmRNSPartial Correction
19th Jun 20073:33 pmRNSStatement re Affiliated Co
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.